19 February 2018 Novel liposomal technology applied in esophageal cancer treatment
Author Affiliations +
Proceedings Volume 10495, Biophotonics and Immune Responses XIII; 104950D (2018) https://doi.org/10.1117/12.2291494
Event: SPIE BiOS, 2018, San Francisco, California, United States
Abstract
Cisplatin (CDDP) has been commonly used as a chemotherapeutic drug, mainly used for the treatment of malignant epithelial cell tumors. We have developed a new method based on innovative lipid calcium phosphate, which encapsulated hydrophobic drugs to form liposomal nanoparticles. Esophageal cancer xenograft model was used to investigate the efficacy of liposomal nanoparticles. and it showed good therapeutic efficacy with lower side effects. Liposomal nanoparticles exhibited a better therapeutic effect than that of conventional CDDP.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Chia-Hsien Yeh, Chia-Hsien Yeh, Yei-San Hsieh, Yei-San Hsieh, Pei-wen Yang, Pei-wen Yang, Leaf Huang, Leaf Huang, Yih-Chih Hsu, Yih-Chih Hsu, } "Novel liposomal technology applied in esophageal cancer treatment", Proc. SPIE 10495, Biophotonics and Immune Responses XIII, 104950D (19 February 2018); doi: 10.1117/12.2291494; https://doi.org/10.1117/12.2291494
PROCEEDINGS
5 PAGES


SHARE
Back to Top